FERDINANDOS SKOULIDIS to Cisplatin
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about Cisplatin.
Connection Strength
0.027
-
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC. J Thorac Oncol. 2020 12; 15(12):1919-1927.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.